HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

1,328.283

+26.0782.00%

Number of Gainers:13

Number of Losers:3

Number of Flat:2

PE:- -

High:1,338.994

Open:1,302.395

Low:1,302.395

Close:1,302.205

Volume:515.21M

Turnover:4.86B

Market Cap:890.82B

Float Cap:743.33B

Loading ...

HK Stock Connect Shareholding Changes | Nov 13

ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development

KINTOR PHARMA-B (09939) Plans to Issue 30.4875 Million Subscription Shares at 15.03% Discount, Raising Approximately HK$49.78 Million

BRIEF-Kintor Pharmaceutical To Allot And Issue Aggregate 30.5 Mln Shares At HK$1.64 Per Share

Kintor Pharmaceutical Announces Private Placement of New Shares

Kintor Pharmaceutical - to Allot and Issue Aggregate 30.5 Mln Shares at Subscription Price HK$1.64 per Share

THOMSON REUTERS

Ministry of Industry and Information Technology Seeks Public Feedback on Draft "National Medical Reserve Management Measures"

CSPC PHARMA (01093): Marketing Application for Pertuzumab Injection Accepted by China's NMPA

CSPC Pharmaceutical Group Pertuzumab Injection Marketing Application Accepted by NMPA

CSPC Pharmaceutical - Nmpa Accepts Marketing Authorisation for Pertuzumab Injection

THOMSON REUTERS

Sinopharm Group Stock Rallies 2.2% in Hong Kong

JD Health International Stock Advances 5.3% in Hong Kong

Ascletis Pharma (SEHK:1672): Evaluating Valuation After Promising Phase Ib Obesity Data and Pipeline Expansion

Simply Wall St.

Pharma Stocks Surge with 20% Intraday Rally; Oil Sector Bucks Market Downtrend

3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 30%

Simply Wall St.

A-Shares Rebound from Early Losses, Healthcare Stocks Lead Gains While Computing Hardware Lags

HK Stock Movement | JD HEALTH (06618) Rises Over 4% as Analysts Expect Continued Revenue Growth Momentum with Steady Drug Sales

Top Private Equity Funds Favor Tech and Healthcare, Financials Get Heavy Allocation

HK Stock Connect Shareholding Changes | November 12

Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1515/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1328.283,"timestamp":1763021314092,"preClose":1302.2053,"halted":0,"volume":515205101,"delay":0,"changeRate":0.020026,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":26.077637,"latestTime":"11-13 16:00:00","open":1302.3949,"high":1338.9937,"low":1302.3949,"amount":4863729637,"amplitude":0.028105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763083800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762997400000,1763006400000],[1763010000000,1763020800000]],"pbRate":2.485043,"peRate":26.810125,"turnoverRate":0.006794,"increases":13,"decrements":3,"flats":1,"marketCap":890823502400,"floatMarketCap":743327962944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1338.9937,"amplitude":0.028105,"preClose":1302.2053,"low":1302.3949,"pbRate":"2.485043","latestPrice":1328.283,"volume":515205101,"delay":0,"open":1302.3949,"prevYearClose":787.97723,"prevWeekClose":1243.435,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1268.661,"twentyDayClose":1383.431,"sixtyDayClose":1440.992,"secType":"PLATE","market":"HK","turnoverRate":0.006794,"peRate":26.810125,"marketCap":890823502400,"floatMarketCap":743327962944,"timestamp":1763021314092,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":13,"down":3,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133667782","title":"HK Stock Connect Shareholding Changes | Nov 13","url":"https://stock-news.laohu8.com/highlight/detail?id=1133667782","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133667782?lang=en_us&edition=fundamental","pubTime":"2025-11-13 08:38","pubTimestamp":1762994314,"startTime":"0","endTime":"0","summary":"According to data disclosed on November 12, 2025, HAO TIAN INTL (01341), REPT BATTERO (00666), and ANJOY FOOD (02648) recorded the largest increases in HK Stock Connect shareholding ratios, rising by...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","LU0348805143.USD","LU2293587155.HKD","BK1235","BK1202","BK1175","09606","BK1576","LU0561508036.HKD","LU0293314216.USD","LU2476274308.USD","LU1794554557.SGD","LU0052750758.USD","00670","06865","BK1144","LU0540923850.HKD","LU0828237940.HKD","09885","LU2328871848.SGD","01276","BK1610","BK1149","LU2543165471.USD","BK1184","HK0000252152.HKD","BK1198","02273","LU1808992512.USD","01333","01138","BK1500","LU1282651121.HKD","LU1497734951.SGD","LU0405327494.USD","BK1530","BK1209","06869","LU0417516738.SGD","02208","BK1225","BK1521","LU0417516902.SGD","BK1510","BK1570","LU0359201885.HKD","09696","LU1303224171.USD","00857","02828","02255","BK1123","06693","02727","BK1183","LU0348825331.USD","LU1046422090.SGD","02050","BK1516","IE00BGV7N243.SGD","BK1556","00525","LU0244354667.USD","LU1497733631.SGD","LU1813983027.USD","03800","03759","BK1535","BK1561","LU0287142896.SGD","00956","BK1221","LU2097828805.USD","LU0307460666.USD","01635","LU0164865239.USD","BK1166","LU2097828714.EUR","01787","01072","BK1565","BK1596","LU0348735423.USD","BK1584","LU0531971595.HKD","LU2097828474.EUR","BK1515","BK1604","02013","00568","BK1096","BK1169","03866","00666","BK1109","02648","01709","BK1506","00168","LU1720050803.USD","01773","03369","LU0327786744.USD","01515","BK1191","LU0072462343.USD","LU1522347837.USD","LU0359202008.SGD","SG9999001093.SGD","00826","LU1188198961.HKD","BK1161","BK1224","IE00B19Z5X02.USD","BK1179","LU0634319403.HKD","BK1590","BK1568","01053","MCHmain","LU0588546209.SGD","LU0359201612.USD","HK0000500386.USD","01341","BK1544","IE00BQJZWZ67.USD","BK1141","LU0871576103.HKD","BK1219","BK1241","02533","01880","BK1505","IE0032431581.USD","SG9999003461.SGD","BK1228","LU0708995583.HKD","06127","BK1560","SG9999012744.USD","LU1634259391.SGD","IE00BWDBJ730.SGD","BK1550","LU1497733557.USD","BK1528","BK1236","LU2399975544.HKD","BK1163","BK1237","BK1171","BK1589","LU0173614495.USD","LU0348783662.USD","BK1522","01171","BK1546","SG9999014674.SGD","BK1226","BK1607","LU0326950275.SGD","BK1138","BK1526","LU1831875114.USD","01766","BK1513","LU1023057109.AUD","06655","HK0000165453.HKD","BK1147","LU1328277881.USD","02666","BK1523","LU0314109678.HKD","BK1129","LU0348784397.USD","LU2039709279.SGD","LU0039217434.USD","BK1587","LU1282651048.USD","LU0348827113.USD","LU0572944931.SGD","LU2097828557.USD","BK1511","LU0611395673.USD","BK1135","BK1110","BK1594","LU0417516571.SGD","00763","BK1197","01877","LU1224444064.USD","00187","01478","02865","BK1173","BK1538","BK1514","01071","LU0469268626.HKD","LU0640798160.USD","LU1115378108.SGD","LU0320764599.SGD","BK1205","BK1583","02465","LU1634259557.SGD","BK1504","SG9999012710.SGD","LU1251922891.USD","BK1186","BK1554","LU0140636845.USD","SG9999012736.USD","BK1180","02628","LU0181495838.USD","06616","BK1178","BK1529","LU0211977185.USD","SG9999012728.SGD","HK0000252160.HKD","BK1558","03931","03347","BK1518","SG9999006597.SGD","BK1125","LU1969619763.USD","BK1578","LU0463099449.HKD","LU1719994722.HKD","BK1116","BK1567","LU1961090484.USD","BK1503","BK1592","LU1048588211.SGD","LU1770034418.SGD","LU0405327148.USD","LU2097828631.EUR","LU2778985437.USD","01282"],"gpt_icon":1},{"id":"1162352611","title":"ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1162352611","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162352611?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:36","pubTimestamp":1762990584,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that its monthly-dose next-generation amylin receptor agonist ASC36 and GLP-1R/GIPR dual-target agonist ASC35 combination therapy has entered clinical development. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4144","GIPR","BK4160","BK1161","BK1515","01477","BK1191","GLP","01672","BK1574"],"gpt_icon":0},{"id":"1163162327","title":"KINTOR PHARMA-B (09939) Plans to Issue 30.4875 Million Subscription Shares at 15.03% Discount, Raising Approximately HK$49.78 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1163162327","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163162327?lang=en_us&edition=fundamental","pubTime":"2025-11-12 23:00","pubTimestamp":1762959613,"startTime":"0","endTime":"0","summary":"KINTOR PHARMA-B (09939) announced on November 12, 2025, that the company intends to issue 30.4875 million subscription shares to Huayuan Management Consulting (Hong Kong) Limited, wholly owned by...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1515","09939"],"gpt_icon":0},{"id":"2582490370","title":"BRIEF-Kintor Pharmaceutical To Allot And Issue Aggregate 30.5 Mln Shares At HK$1.64 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2582490370","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582490370?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:57","pubTimestamp":1762959451,"startTime":"0","endTime":"0","summary":"BRIEF-Kintor Pharmaceutical To Allot And Issue Aggregate 30.5 Mln Shares At HK$1.64 Per ShareNov 12  - Kintor Pharmaceutical Ltd 9939.HK:TO ALLOT AND ISSUE AGGREGATE 30.5 MILLION SHARES AT SUBSCRIPTION PRICE HK$1.64 PER SHAREFurther company coverage: 9939.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2582370459","title":"Kintor Pharmaceutical Announces Private Placement of New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370459","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582370459?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:57","pubTimestamp":1762959442,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical Ltd. has announced that it has entered into a subscription agreement on November 12, 2025, for the issuance of new shares under a general mandate. The agreement with the subscriber involves a private placement of shares, but the company notes that the subscription may or may not proceed to completion. Shareholders and potential investors are advised to exercise caution when dealing in the company's securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3s6rmf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2582968370","title":"Kintor Pharmaceutical - to Allot and Issue Aggregate 30.5 Mln Shares at Subscription Price HK$1.64 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2582968370","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582968370?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:53","pubTimestamp":1762959205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"1101597869","title":"Ministry of Industry and Information Technology Seeks Public Feedback on Draft \"National Medical Reserve Management Measures\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1101597869","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101597869?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:30","pubTimestamp":1762943432,"startTime":"0","endTime":"0","summary":"The Ministry of Industry and Information Technology (MIIT), through its Consumer Goods Industry Department, has revised the \"National Medical Reserve Management Measures (2021 Revision)\" (MIIT-Lian...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"1113577710","title":"CSPC PHARMA (01093): Marketing Application for Pertuzumab Injection Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1113577710","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113577710?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:16","pubTimestamp":1762942594,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) announced that the marketing application for Pertuzumab Injection, developed by its subsidiary CSPC JUSHI BIOPHARMACEUTICAL CO., LTD., has been accepted by China's National...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287875.USD","LU1993786604.SGD","LU1008478684.HKD","LU1960683339.HKD","BK1515","LU1152091168.USD","LU0072913022.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1328277881.USD","IE0008368742.USD","SG9999004220.SGD","LU0067412154.USD","LU0326950275.SGD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU2039709279.SGD","BK1191","BK1521","LU1152091754.HKD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","LU0140636845.USD","HK0000165453.HKD","LU0314109678.HKD","IE0008369823.USD","01093","LU0880133367.SGD","LU1807302812.USD","LU1226288170.HKD","LU0315179316.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1226288253.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2582324700","title":"CSPC Pharmaceutical Group Pertuzumab Injection Marketing Application Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2582324700","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582324700?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:05","pubTimestamp":1762941950,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Ltd. has announced that its marketing authorisation application for Pertuzumab Injection has been accepted by the National Medical Products Administration  of China. Developed by its subsidiary CSPC Megalith Biopharmaceutical Co., Ltd., the biosimilar product is intended for the treatment of HER2-positive breast cancer. The application is primarily supported by results from a Phase III equivalence clinical trial, which demonstrated that the product is highly similar to the reference drug in terms of efficacy, safety, and tolerability. The application is currently under regulatory review. No grant or funding from multiple organizations was mentioned in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL78WD56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226287792.SGD","LU1152091168.USD","LU1813983027.USD","LU1951186391.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226288170.HKD","LU1807302812.USD","LU1993786604.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","BK1191","IE00B543WZ88.USD","LU0072913022.USD","LU0501845795.SGD","IE0008369823.USD","LU1960683339.HKD","BK1515","LU1226288253.USD","LU0315179316.USD","LU0880133367.SGD","01093","LU1152091754.HKD","LU0067412154.USD","BK1521","IE00BZ08YS42.EUR","SG9999004220.SGD","LU1328277881.USD","HK0000165453.HKD","LU1226287529.USD","LU0314109678.HKD","LU0140636845.USD"],"gpt_icon":0},{"id":"2582242103","title":"CSPC Pharmaceutical - Nmpa Accepts Marketing Authorisation for Pertuzumab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2582242103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582242103?lang=en_us&edition=fundamental","pubTime":"2025-11-12 18:01","pubTimestamp":1762941677,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO09B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2039709279.SGD","LU1226287875.USD","01093","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","LU0314109678.HKD","IE00B031HY20.USD","LU1226288170.HKD","BK1191","LU1152091168.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU0072913022.USD","LU1226288253.USD","BK1515","LU1993786604.SGD","LU1328277881.USD","LU1152091754.HKD","LU0326950275.SGD","LU1226287529.USD","SG9999004220.SGD","LU1813983027.USD","LU0140636845.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1807302812.USD","LU1008478684.HKD","LU0315179316.USD","LU1960683339.HKD","IE00B543WZ88.USD","IE0008369823.USD","LU1226287792.SGD","BK1521","LU0067412154.USD","IE0008368742.USD","LU0880133367.SGD"],"gpt_icon":0},{"id":"2582255293","title":"Sinopharm Group  Stock Rallies 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2582255293","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582255293?lang=en_us&edition=fundamental","pubTime":"2025-11-12 16:33","pubTimestamp":1762936380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 2.2% to 21.34 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 26922.73.This was the stock's seventh consecutive day of gains.Sinopharm Group Co. Ltd. closed 4.5% short of its 52-week high of HK$22.35, which the company achieved Dec. 16.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.4%.Trading volume totaled 10.5 million shares, compared to the 50-day average of 5.4 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1197","SHTDY","BK1515","BK4175","LU0640798160.USD","01099","LU1115378108.SGD"],"gpt_icon":0},{"id":"2582374325","title":"JD Health International Stock Advances 5.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2582374325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582374325?lang=en_us&edition=fundamental","pubTime":"2025-11-12 16:30","pubTimestamp":1762936200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rose 5.3% to 64.70 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 26922.73.JD Health International Inc. closed 8.1% below its 52-week high of HK$70.40, which the company achieved Sept. 12.Trading volume totaled 9.4 million shares, compared to the 50-day average of 7.3 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK4524","BK4588","BK1571","BK4503","BK1515","IE00BGV7N243.SGD","LU0463099449.HKD","LU0051755006.USD","IE0008368742.USD","BK4509","BK4558","BK4220","BK4585","SGXZ86797644.SGD","86618","LU1688375341.USD","HK0000320264.USD","LU0106959298.USD","BK4551","LU1880383366.USD","BK1591","SG9999002463.SGD","LU0456827905.SGD","LU1188198961.HKD","BK1247","06618","HK0000306685.HKD","BK4579","SGXZ62798434.SGD","HK0000306701.USD","LU0244354667.USD","BK1142","BK4526","LU0307460666.USD","BK4614","BK4505","LU0326950275.SGD","BK4122","BK4531","LU0588546209.SGD","BK4504","BK1615","BK1583","HK0000320223.HKD"],"gpt_icon":1},{"id":"2582329905","title":"Ascletis Pharma (SEHK:1672): Evaluating Valuation After Promising Phase Ib Obesity Data and Pipeline Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2582329905","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582329905?lang=en_us&edition=fundamental","pubTime":"2025-11-12 14:21","pubTimestamp":1762928503,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) has captured attention after sharing new Phase Ib data for its ASC30 oral tablet and injection. The results demonstrated up to 7% placebo-adjusted mean body weight reduction and strong safety signals, with only mild gastrointestinal issues reported.\nSee our latest analysis for Ascletis Pharma.\nAscletis Pharma’s rapid progress in its clinical obesity programs has sparked a flurry of investor enthusiasm, helping fuel a 243.5% year-to-date share price return. While...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-evaluating-valuation-after-promisin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/ascletis-pharma-sehk1672-evaluating-valuation-after-promisin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","01672","BK1574","BK1161"],"gpt_icon":0},{"id":"1138234515","title":"Pharma Stocks Surge with 20% Intraday Rally; Oil Sector Bucks Market Downtrend","url":"https://stock-news.laohu8.com/highlight/detail?id=1138234515","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138234515?lang=en_us&edition=fundamental","pubTime":"2025-11-12 12:30","pubTimestamp":1762921837,"startTime":"0","endTime":"0","summary":"A-shares saw modest fluctuations in early trading, with the Shanghai Composite Index consolidating around 4,000 points. The ChiNext Index, Shenzhen Component Index, BSE 50, and STAR 50 all fell over...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1515","BK1161","159938"],"gpt_icon":0},{"id":"2582346604","title":"3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582346604","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582346604?lang=en_us&edition=fundamental","pubTime":"2025-11-12 12:07","pubTimestamp":1762920471,"startTime":"0","endTime":"0","summary":"As global markets face fluctuations, with concerns about elevated valuations and economic uncertainties in major regions like the U.S. and Europe, Asia presents intriguing opportunities for investors seeking value. In this environment, identifying undervalued stocks—those trading below their intrinsic worth—can be a strategic approach to potentially benefit from market inefficiencies and capture future growth prospects.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/tech/hkg-285/byd-electronic-international-shares/news/3-asian-stocks-estimated-to-be-trading-at-discounts-of-up-to-20","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/tech/hkg-285/byd-electronic-international-shares/news/3-asian-stocks-estimated-to-be-trading-at-discounts-of-up-to-20","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00285","BK4588","BK1504","BK1607","BK4544","ARKG","BK1149","BK1540","BK1580","BK4585","LU0274383008.USD","LU0348767384.USD","LU0348766576.USD","BK1582","BK1589","BK1515"],"gpt_icon":0},{"id":"1151695811","title":"A-Shares Rebound from Early Losses, Healthcare Stocks Lead Gains While Computing Hardware Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=1151695811","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151695811?lang=en_us&edition=fundamental","pubTime":"2025-11-12 10:20","pubTimestamp":1762914031,"startTime":"0","endTime":"0","summary":"A-shares opened lower but reversed course, with all three major indices turning positive. The Shanghai Composite Index rose 0.4%, while the ChiNext Index gained 0.03% after earlier dropping over 1%....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","399300","159938","BK1574","09939","159982"],"gpt_icon":0},{"id":"1131113643","title":"HK Stock Movement | JD HEALTH (06618) Rises Over 4% as Analysts Expect Continued Revenue Growth Momentum with Steady Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1131113643","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131113643?lang=en_us&edition=fundamental","pubTime":"2025-11-12 10:16","pubTimestamp":1762913776,"startTime":"0","endTime":"0","summary":"JD HEALTH (06618) surged more than 4%, reaching HK$64.05 by the time of writing, with a trading volume of HK$162 million. A research report from CLSA noted that JD HEALTH maintained robust...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06618","SGXZ62798434.SGD","SGXZ86797644.SGD","86618","BK1142","BK1247","BK1615","BK1583","BK1591","LU0456827905.SGD","BK1571","BK1589","LU0051755006.USD","BK1515"],"gpt_icon":0},{"id":"1118604871","title":"Top Private Equity Funds Favor Tech and Healthcare, Financials Get Heavy Allocation","url":"https://stock-news.laohu8.com/highlight/detail?id=1118604871","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118604871?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:11","pubTimestamp":1762909918,"startTime":"0","endTime":"0","summary":"Recent monthly reports from multiple private equity funds reveal the latest investment strategies of major players in the market. As key participants, the moves of billion-dollar private equity funds...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","09939","159940","BK1515"],"gpt_icon":0},{"id":"1181014719","title":"HK Stock Connect Shareholding Changes | November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1181014719","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181014719?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:38","pubTimestamp":1762907908,"startTime":"0","endTime":"0","summary":"As of November 11, 2025, data shows that HAO TIAN INTL (01341), REPT BATTERO (00666), and CTG DUTY-FREE (01880) recorded the largest increases in Stock Connect shareholding ratios, rising by 1.72%,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02465","02828","BK1147","BK1129","BK1590","BK1587","02631","BK1521","00874","LU0348825331.USD","BK1574","BK1500","BK1555","03931","BK1228","BK1567","LU1983299162.USD","BK1170","BK1515","BK1522","BK1197","03759","01071","BK1588","BK1594","BK1610","LU0326950275.SGD","BK1518","BK1556","HK0000252152.HKD","02402","IE00BZ08YT58.USD","LU1720050803.USD","BK1596","LU0417516738.SGD","BK1530","BK1240","06616","BK1161","02562","BK1148","IE00BZ08YR35.GBP","LU0417516902.SGD","BK1523","LU0052750758.USD","02533","BK1236","00666","09688","BK1511","LU1969619763.USD","00763","03800","BK1564","00902","03678","02382","BK1109","LU0708995583.HKD","BK1568","MCHmain","LU1794554557.SGD","BK1526","00568","02865","02837","BK1205","01773","00956","09885","SG9999003461.SGD","BK1171","02648","LU0588546209.SGD","BK1191","02162","BK1607","00119","BK1116","BK1513","IE00B29SXG58.USD","LU2543165471.USD","BK1503","01053","01709","BK1237","BK1582","BK1576","LU1831875114.USD","BK1554","BK1613","00095","BK1125","BK1141","00968","00525","00187","00189","BK1219","BK1558","01347","06865","BK1614","BK1505","01072","BK1589","06682","BK1546","LU2328871848.SGD","BK1608","HK0000252160.HKD","06869","BK1529","09995","IE0034224299.USD","BK1138","BK1149","BK1224","03347","BK1110","BK1504","BK1144","BK1516","LU1211504680.USD","BK1560","01877","01880","02587","03866","BK1163","02013","02255","09606","LU0307460666.USD","02068","BK1183","06680","LU2488822045.USD","SG9999014674.SGD","BK1169","BK1235","BK1241","SG9999006597.SGD","02050","09696","IE00BZ08YS42.EUR","01282","02727","BK1202","BK1225","HK0000500386.USD","06613","BK1583","06955","02208","LU0348735423.USD","BK1506","BK1606","BK1166","LU0320764599.SGD","01341"],"gpt_icon":1},{"id":"1100166005","title":"Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1100166005","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100166005?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:52","pubTimestamp":1762869138,"startTime":"0","endTime":"0","summary":"On November 11, shares of pharmaceutical giant AstraZeneca PLC (AZN) rose 2.5% intraday to £134.6, setting a new all-time high. With its market capitalization nearing £210 billion ($282 billion), the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1574","LU2456880835.USD","LU2236285917.USD","BK4568","LU0320765992.SGD","LU1829250122.USD","LU0889565916.HKD","BK4007","09939","LU2417539215.USD","BK1161","BK4585","LU0109394709.USD","LU2462157665.USD","159938","BK1515","AZN"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":185,"code":"91000000","status":"200"}]}}